Schizophrenia & Psychoses

Schizophrenia Relapse Rate Lower With Injectable Versus Oral Antipsychotics

Schizophrenia Relapse Rate Lower With Injectable Versus Oral Antipsychotics

By

The risk for rehospitalization was 22% lower during treatment with long-acting injectable antipsychotic medications compared with treatment with equivalent oral formulations in the total cohort.

Schizophrenia Symptoms May Benefit From Specific Kind of Talk Therapy

Schizophrenia Symptoms May Benefit From Specific Kind of Talk Therapy

Schizophrenia patients may benefit from a a specific type of talk therapy, according to a new study from the University of Pennsylvania.

Concomitant Use of Antidepressants, Antipsychotics Linked to T2D Risk

Concomitant Use of Antidepressants, Antipsychotics Linked to T2D Risk

By

Concomitant SSRI/SNRI use was associated with an increased diabetes risk in AAP-treated young people.

Schizophrenia: Are There Any Effective Pharmacologic Combinations?

Schizophrenia: Are There Any Effective Pharmacologic Combinations?

By

There is currently no approved drug combination for treatment-resistant schizophrenia.

Cardiometabolic Outcomes in Schizophrenia Improved by Liraglutide

Cardiometabolic Outcomes in Schizophrenia Improved by Liraglutide

By

In patients with schizophrenia being treated with clozapine or olanzapine, liraglutide significantly improved glucose tolerance, body weight, and other cardiometabolic disturbances.

Schizophrenia Treatment Can Benefit From Electroconvulsive Therapy

Schizophrenia Treatment Can Benefit From Electroconvulsive Therapy

By

Electroconvulsive therapy can be a clinically effective treatment for patients with severe forms of schizophrenia.

Valbenazine Effective for Tardive Dyskinesia in Schizophrenia

Valbenazine Effective for Tardive Dyskinesia in Schizophrenia

By

Long-term valbenazine may be beneficial in managing tardive dyskinesia.

BMI In Schizophrenia Patients Associated With C-reactive Protein

BMI In Schizophrenia Patients Associated With C-reactive Protein

By

Body mass index in patients with schizophrenia is linked to C-reactive protein.

Adolescents With Schizophrenia Prove Able to Tolerate Lurasidone

Adolescents With Schizophrenia Prove Able to Tolerate Lurasidone

By

Lurasidone is an atypical antipsychotic that has demonstrated efficacy in the treatment of schizophrenia in adolescents.

Psychotropic Medication Heightens Risk of Hip Fracture, MOF

Psychotropic Medication Heightens Risk of Hip Fracture, MOF

By

Mental disorders and psychotropic medication use are associated with an increased risk for fracture but are not fully captured by FRAX tool.

Antipsychotic Nonadherence Due to Social Stigma

Antipsychotic Nonadherence Due to Social Stigma

By

Schizophrenia was perceived as more distressful and with higher perceived social stigma than other disorders.

Schizophrenia Patients on Multiple Drugs Experience Cognitive Burden

Schizophrenia Patients on Multiple Drugs Experience Cognitive Burden

By

Scientists researched the association between multiple drug treatments for psychotic disorders and anticholinergic burden.

Schizophrenia Risk Linked to Cannabis Use

Schizophrenia Risk Linked to Cannabis Use

By

Cannabis is the most widely misused illicit drug.

Schizophrenia Associated With Years of Life Lost

Schizophrenia Associated With Years of Life Lost

By

Schizophrenia was associated with 13 to 15 years of potential life lost.

Low Prenatal Weight Gain Linked to Offspring Psychosis Risk

Low Prenatal Weight Gain Linked to Offspring Psychosis Risk

By

The risk for offspring's development of psychosis is connected to maternal weight gain during pregnancy.

Antipsychotic Adherence Boosted by Financial Incentives

Antipsychotic Adherence Boosted by Financial Incentives

By

A trial at 3 mental health centers in The Netherlands revealed that patients with financial incentives have better compliance.

Schizophrenia Symptoms Reduced by Vitamin B

Adding high-dose B vitamins to traditional antipsychotic treatments reduces schizophrenia symptoms more than traditional treatments alone.

FDA Approves New Schizophrenia Treatment for Adolescents

FDA Approves New Schizophrenia Treatment for Adolescents

By

The FDA has approved a new treatment for adolescents between the ages of 13 and 17 years who are diagnosed with schizophrenia.

Factors Predicting Favorable Outcomes in First-Episode Psychosis Without Medication

Factors Predicting Favorable Outcomes in First-Episode Psychosis Without Medication

By

Researchers profiled which young people may do well after first-episode psychosis without medication.

Low-Dose Metformin May Reduce Body Weight and BMI in Clozapine-Treated Schizophrenia

Low-Dose Metformin May Reduce Body Weight and BMI in Clozapine-Treated Schizophrenia

By

These study results indicate that early intervention with low doses of metformin in patients with few metabolic abnormalities may be beneficial.

Childhood Trauma, Depression Associated With Impaired Quality of Life in Schizophrenia

Childhood Trauma, Depression Associated With Impaired Quality of Life in Schizophrenia

By

Targeting negative symptoms in patients with schizophrenia may be more effective in improving patients' QoL.

Cardiometabolic Factors in Youth Schizophrenia Treatment

Cardiometabolic Factors in Youth Schizophrenia Treatment

By

Pretreatment cardiometabolic status to be taken into consideration for treatment of first episode psychosis.

Facial Affect Recognition Training Improves Social Outcomes in Psychosis

Facial Affect Recognition Training Improves Social Outcomes in Psychosis

By

Inability to interpret facial expressions may exacerbate psychotic symptoms, either indirectly via social defeat or directly by creating confusing interpersonal experiences.

Pediatric Patients Should Undergo Electrocardiogram Assessment Before Antipsychotic Treatment

Pediatric Patients Should Undergo Electrocardiogram Assessment Before Antipsychotic Treatment

By

Cardiac safety is integral to child and adolescent antipsychotic therapy.

Schizophrenia Linked to Type 2 Diabetes

Schizophrenia Linked to Type 2 Diabetes

Patients with early schizophrenia may have already started down the road to diabetes, even prior to actual diagnosis.

Antipsychotic Switching in Schizophrenia: Immediate vs Gradual Discontinuation

Antipsychotic Switching in Schizophrenia: Immediate vs Gradual Discontinuation

By

Both immediate and gradual discontinuation of the current antipsychotic medication are viable treatment options.

First-Episode Schizophrenia Approaches Aided by Guidelines Instrument

First-Episode Schizophrenia Approaches Aided by Guidelines Instrument

By

Clinical practice guidelines are important resources for early intervention in a first episode of schizophrenia.

Art Therapy as an Intervention for Psychosis

Art Therapy as an Intervention for Psychosis

By

A patient does not have to be verbal to benefit from art therapy.

Schizophrenia Patient Dead After UTI Treatment

Schizophrenia Patient Dead After UTI Treatment

By

This case offers evidence of the interaction between ciprofloxacin and clozapine.

Mindfulness Intervention Effective for Distressing Voices in Psychosis

Mindfulness Intervention Effective for Distressing Voices in Psychosis

By

Combined cognitive therapy and mindfulness can have lasting positive effects on behavior and mood.

Sign Up for Free e-newsletters